Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2003 May;58(5):388–393. doi: 10.1136/thorax.58.5.388

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

D Mannino 1, A Buist 1, T Petty 1, P Enright 1, S Redd 1
PMCID: PMC1746680  PMID: 12728157

Abstract

Background: A study was undertaken to define the risk of death among a national cohort of US adults both with and without lung disease.

Methods: Participants in the first National Health and Nutrition Examination Survey (NHANES I) followed for up to 22 years were studied. Subjects were classified using a modification of the Global Initiative for Chronic Obstructive Lung Disease criteria for chronic obstructive pulmonary disease (COPD) into the following mutually exclusive categories using the forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and the presence of respiratory symptoms: severe COPD, moderate COPD, mild COPD, respiratory symptoms only, restrictive lung disease, and no lung disease. Proportional hazard models were developed that controlled for age, race, sex, education, smoking status, pack years of smoking, years since quitting smoking, and body mass index.

Results: A total of 1301 deaths occurred in the 5542 adults in the cohort. In the adjusted proportional hazards model the presence of severe or moderate COPD was associated with a higher risk of death (hazard ratios (HR) 2.7 and 1.6, 95% confidence intervals (CI) 2.1 to 3.5 and 1.4 to 2.0), as was restrictive lung disease (HR 1.7, 95% CI 1.4 to 2.0).

Conclusions: The presence of both obstructive and restrictive lung disease is a significant predictor of earlier death in long term follow up.

Full Text

The Full Text of this article is available as a PDF (129.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaron S. D., Dales R. E., Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest. 1999 Mar;115(3):869–873. doi: 10.1378/chest.115.3.869. [DOI] [PubMed] [Google Scholar]
  2. Anthonisen N. R. Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis. 1989 Sep;140(3 Pt 2):S95–S99. doi: 10.1164/ajrccm/140.3_Pt_2.S95. [DOI] [PubMed] [Google Scholar]
  3. Bang K. M., Gergen P. J., Kramer R., Cohen B. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest. 1993 Feb;103(2):536–540. doi: 10.1378/chest.103.2.536. [DOI] [PubMed] [Google Scholar]
  4. Burrows B., Bloom J. W., Traver G. A., Cline M. G. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987 Nov 19;317(21):1309–1314. doi: 10.1056/NEJM198711193172103. [DOI] [PubMed] [Google Scholar]
  5. Camilli A. E., Robbins D. R., Lebowitz M. D. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol. 1991 Apr 15;133(8):795–800. doi: 10.1093/oxfordjournals.aje.a115958. [DOI] [PubMed] [Google Scholar]
  6. Cohen B. B., Barbano H. E., Cox C. S., Feldman J. J., Finucane F. F., Kleinman J. C., Madans J. H. Plan and operation of the NHANES I Epidemiologic Followup Study: 1982-84. Vital Health Stat 1. 1987 Jun;(22):1–142. [PubMed] [Google Scholar]
  7. Cox C. S., Mussolino M. E., Rothwell S. T., Lane M. A., Golden C. D., Madans J. H., Feldman J. J. Plan and operation of the NHANES I Epidemiologic Followup Study, 1992. Vital Health Stat 1. 1997 Dec;(35):1–231. [PubMed] [Google Scholar]
  8. Cox C. S., Rothwell S. T., Madans J. H., Finucane F. F., Freid V. M., Kleinman J. C., Barbano H. E., Feldman J. J. Plan and operation of the NHANES I Epidemiologic Followup Study, 1987. Vital Health Stat 1. 1992 Sep;(27):1–190. [PubMed] [Google Scholar]
  9. Engström G., Hedblad B., Janzon L., Valind S. Respiratory decline in smokers and ex-smokers--an independent risk factor for cardiovascular disease and death. J Cardiovasc Risk. 2000 Aug;7(4):267–272. doi: 10.1177/204748730000700404. [DOI] [PubMed] [Google Scholar]
  10. Ferguson G. T., Enright P. L., Buist A. S., Higgins M. W. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest. 2000 Apr;117(4):1146–1161. doi: 10.1378/chest.117.4.1146. [DOI] [PubMed] [Google Scholar]
  11. Finucane F. F., Freid V. M., Madans J. H., Cox C. S., Kleinman J. C., Rothwell S. T., Barbano H. E., Feldman J. J. Plan and operation of the NHANES I Epidemiologic Followup Study, 1986. Vital Health Stat 1. 1990 Sep;(25):1–154. [PubMed] [Google Scholar]
  12. Hole D. J., Watt G. C., Davey-Smith G., Hart C. L., Gillis C. R., Hawthorne V. M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996 Sep 21;313(7059):711–716. doi: 10.1136/bmj.313.7059.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hospers J. J., Postma D. S., Rijcken B., Weiss S. T., Schouten J. P. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet. 2000 Oct 14;356(9238):1313–1317. doi: 10.1016/S0140-6736(00)02815-4. [DOI] [PubMed] [Google Scholar]
  14. Hunt L. W., Jr, Silverstein M. D., Reed C. E., O'Connell E. J., O'Fallon W. M., Yunginger J. W. Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA. 1993 Apr 21;269(15):1947–1952. [PubMed] [Google Scholar]
  15. Knuiman M. W., James A. L., Divitini M. L., Ryan G., Bartholomew H. C., Musk A. W. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol. 1999 Jul;9(5):297–306. doi: 10.1016/s1047-2797(98)00066-0. [DOI] [PubMed] [Google Scholar]
  16. Maltais F., LeBlanc P., Jobin J., Casaburi R. Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med. 2000 Dec;21(4):665–677. doi: 10.1016/s0272-5231(05)70176-3. [DOI] [PubMed] [Google Scholar]
  17. Mannino D. M., Gagnon R. C., Petty T. L., Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000 Jun 12;160(11):1683–1689. doi: 10.1001/archinte.160.11.1683. [DOI] [PubMed] [Google Scholar]
  18. Neas L. M., Schwartz J. Pulmonary function levels as predictors of mortality in a national sample of US adults. Am J Epidemiol. 1998 Jun 1;147(11):1011–1018. doi: 10.1093/oxfordjournals.aje.a009394. [DOI] [PubMed] [Google Scholar]
  19. O'Brien R. J., Drizd T. A. Basic data on spirometry in adults 25-74 years of age: United States, 1971-75. Vital Health Stat 11. 1981 Mar;(222):1–36. [PubMed] [Google Scholar]
  20. Pauwels R. A., Buist A. S., Calverley P. M., Jenkins C. R., Hurd S. S., GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001 Apr;163(5):1256–1276. doi: 10.1164/ajrccm.163.5.2101039. [DOI] [PubMed] [Google Scholar]
  21. Pelkonen M., Tukiainen H., Tervahauta M., Notkola I. L., Kivelä S. L., Salorinne Y., Nissinen A. Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax. 2000 Sep;55(9):746–750. doi: 10.1136/thorax.55.9.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Postma D. S., Sluiter H. J. Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am Rev Respir Dis. 1989 Sep;140(3 Pt 2):S100–S105. doi: 10.1164/ajrccm/140.3_Pt_2.S100. [DOI] [PubMed] [Google Scholar]
  23. Rahman I., MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax. 1996 Apr;51(4):348–350. doi: 10.1136/thx.51.4.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Repine J. E., Bast A., Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):341–357. doi: 10.1164/ajrccm.156.2.9611013. [DOI] [PubMed] [Google Scholar]
  25. Ryan G., Knuiman M. W., Divitini M. L., James A., Musk A. W., Bartholomew H. C. Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health. 1999 Apr;53(4):230–234. doi: 10.1136/jech.53.4.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schünemann H. J., Dorn J., Grant B. J., Winkelstein W., Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000 Sep;118(3):656–664. doi: 10.1378/chest.118.3.656. [DOI] [PubMed] [Google Scholar]
  27. Sharp D. S., Masaki K., Burchfiel C. M., Yano K., Schatz I. J. Prolonged QTc interval, impaired pulmonary function, and a very lean body mass jointly predict all-cause mortality in elderly men. Ann Epidemiol. 1998 Feb;8(2):99–106. doi: 10.1016/s1047-2797(97)00121-x. [DOI] [PubMed] [Google Scholar]
  28. Stewart A. G., Waterhouse J. C., Howard P. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. Respir Med. 1995 Feb;89(2):79–84. doi: 10.1016/0954-6111(95)90188-4. [DOI] [PubMed] [Google Scholar]
  29. Volterrani M., Scalvini S., Mazzuero G., Lanfranchi P., Colombo R., Clark A. L., Levi G. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest. 1994 Nov;106(5):1432–1437. doi: 10.1378/chest.106.5.1432. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES